Reuters reports that a jury in Philadelphia has awarded $3 million in compensatory damages and $75 million in punitive damages to a man who claims he developed cancer from using the weedkiller Roundup.

The article contains some remarkable data about the history of this litigation: the defendants has prevailed in 14 of the 20 Roundup cases that have gone to trial, but the few verdicts that have gone the plaintiffs’ way have been colossal, including one for $1.56 billion and one for $2.25 billion.

Bayer, who is the defendant in these cases because it acquired Roundup manufacturer Monsanto in 2018, maintains its position that “the overwhelming weight of scientific evidence and the consensus of regulatory bodies . . . worldwide” shows that Roundup is safe. Meanwhile, the plaintiff’s lawyers accuse Bayer of “act[ing] with reckless indifference to people’s safety.”

This litigation could come to an end if Bayer can persuade the Supreme Court to weigh in and adopt the view taken by the Third Circuit, which held that federal law preempts state-law claims about the adequacy of the Roundup’s labelling.